Authors
Chang-Seok Yoon, Hong-Joon Shin, Bo-Gun Kho, Sunghoon Park, Su Hwan Lee, Onyu Park, Taehwa Kim, Hye Ju Yeo, Woo Hyun Cho, Chul Park, Joon Hwang, Kang-Moon Park, Tae-Ok Kim, Korean Intensive Care Study Group
Published in
Journal of Korean medical science. Volume 41. Issue 44. Pages e275. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Coronavirus disease 2019 (COVID-19) has been associated with substantial global mortality. Although artificial intelligence (AI)-based models have shown promise for mortality prediction, evidence focused specifically on critically ill patients remains limited. In addition, meaningful clinical implementation requires models that rely on a minimal set of readily available variables to enable rapid risk stratification. This study aimed to develop a deep learning-based model for predicting mortality in critically ill COVID-19 patients requiring intensive care unit (ICU) admission, with an emphasis on efficiency and clinical applicability.
This retrospective multicenter study included 900 critically ill patients with COVID-19 admitted to ICUs across 22 centers in Korea between January 1, 2020, and August 31, 2021. A deep learning-based tabular model was constructed, and systematic feature reduction strategies were applied to optimize predictive performance while enhancing practicality.
Of the 900 patients, 365 (40.6%) survived and 535 (59.4%) died. Compared with survivors, non-survivors were older, demonstrated more severe clinical and chest X-ray (CXR) findings, had lower respiratory rate-oxygenation (ROX) indices, and required vasopressors and continuous renal replacement therapy more frequently (all P < 0.05). The initial model incorporating 66 variables achieved an area under the curve (AUC) of 0.8500. Following stepwise feature selection, the model was reduced to seven key variables (age, C-reactive protein, lactate dehydrogenase, pro-B-type natriuretic peptide, CXR infiltration, CXR consolidation, and ROX index), resulting in a simplified model with an AUC of 0.8247.
A deep learning-based AI model was developed to support clinical decision-making in critically ill patients with COVID-19, offering an efficient and clinically practical approach to mortality risk assessment.
PMID:
43041104
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0